Observational studyAnnals of hematology2024
Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trial.
Fabio Efficace et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it